Cvs Health Corp Cvs Health Corp [CVS] has reported $71 million quarterly profit, an decrease of $1.7 billion from the previous quarter, the company said in a filing to the SEC for the Q3 ended Sep 30, 2024.
CVS Health reported the quarterly diluted earnings per share (EPS) fell by -95.04 percent to $0.1 from $1.4 in the previous quarter.
Dollars in millions | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|
Income Statement |
| Revenue | $95,428.0 | $91,234.0 | $88,437.0 | $357,776.0 |
| Operating Profit | $832.0 | $3,045.0 | $2,271.0 | $13,743.0 |
| Net Income | $71.0 | $1,768.0 | $1,124.0 | $8,368.0 |
| Net Cash | -$1,385.0 | $4,295.0 | $1,582.0 | -$4,780.0 |
| Gross Margin | $42,480.0 | $41,236.0 | $40,364.0 | $140,678.0 |
| Operating Margin | $0.0 | $0.0 | $0.0 | $0.0 |
| Profit as % of Revenues | 59830.99 | 2332.35 | 3591.10 | 39.32 |
| Profit as % of Assets | 0.04 | 1.03 | 0.66 | 3.50 |
| Profit as % of Stockholder Equity | 0.09 | 2.35 | 1.52 | 10.92 |
| Return on Equity | 0.09 | 2.35 | 1.52 | 10.92 |
| Return on Assets | 0.03 | 0.70 | 0.45 | 3.35 |
| Turnover Ratio | 54.87 | 53.09 | 52.30 | 1.50 |
| EBITA | $832.0 | $3,045.0 | $2,271.0 | |
Balance Sheet |
| Total Assets | $252,427.0 | $252,481.0 | $249,743.0 | $249,728.0 |
| Total Liabilities | $177,321.0 | $177,370.0 | $175,593.0 | $173,092.0 |
Cash Flow Statement |
| Operating Cash Flow | $7,247.0 | $7,992.0 | $4,903.0 | $13,426.0 |
| Investing Cash Flow | -$7,066.0 | -$3,719.0 | -$2,094.0 | -$20,889.0 |
| Financing Cash Flow | -$1,566.0 | $22.0 | -$1,227.0 | $2,683.0 |
Disclaimer:USinMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. Although care is taken to ensure accuracy, the article does not intend to replace user diligence in decisions of financial or legal implications.
![Cvs Health Corp [CVS] reports $71 million quarterly net profit](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FCVS_i1.jpg&w=1200&q=75)